June 12, 2024


A U.S. Food and Drug Administration (FDA) database says that most doses of Zepbound will be in limited supply through at least the end June, thanks to increased demand.

A U.S. Food and Drug Administration (FDA) database says that most doses of Zepbound will be in limited supply through at least the end June, thanks to increased demand.
Photo: Brendan McDermid (Reuters)

It may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity medications, according to Eli Lilly’s top leader on weight loss drugs. “Even if we take the combined supply of our [medications] and the competition, it’s not sufficient to meet the needs of 110 million Americans,” President of Lilly Diabetes and Obesity Patrik Jonsson told Quartz in an interview.

Read More



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *